Semaphorin 3d and Semaphorin 3e Direct Endothelial Motility through Distinct Molecular Signaling Pathways
Haig Aghajanian(Therapeutics Clinical Research), Jonathan A. Epstein(California Institute for Regenerative Medicine), Connie Choi(California Institute for Regenerative Medicine), Manvendra K. Singh(National Heart Centre Singapore), Vivienne C. Ho(California Institute for Regenerative Medicine), Mudit Gupta(University of Pennsylvania)
Cited by 70
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
|Genetics in Medicine|2002|398
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|267